{"id":"https://openalex.org/W7221544679","doi":"https://doi.org/10.3389/fimmu.2026.1958441","title":"Antitumor immunity and immune-related toxicity during immune checkpoint inhibition: mechanistic overlap, tissue selectivity, and interventional evidence","display_name":"Antitumor immunity and immune-related toxicity during immune checkpoint inhibition: mechanistic overlap, tissue selectivity, and interventional evidence","publication_year":2026,"publication_date":"2026-10-12","ids":{"openalex":"https://openalex.org/W7221544679","doi":"https://doi.org/10.3389/fimmu.2026.1958441","pmid":"https://pubmed.ncbi.nlm.nih.gov/42935710","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13696943"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1958441","doi":"https://doi.org/10.3389/fimmu.2026.1958441","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1958441","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1958441/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1958441/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5137177969","display_name":"Chengyan Shi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102855","display_name":"First Affiliated Hospital of Heilongjiang University of Chinese Medicine","ror":"https://ror.org/01c0exk17","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210102855"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chengyan Shi","raw_affiliation_strings":["The Second Department of Oncology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Second Department of Oncology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine","institution_ids":["https://openalex.org/I4210102855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158466350","display_name":"Chunhai Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102855","display_name":"First Affiliated Hospital of Heilongjiang University of Chinese Medicine","ror":"https://ror.org/01c0exk17","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210102855"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chunhai Li","raw_affiliation_strings":["The Second Department of Oncology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Second Department of Oncology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine","institution_ids":["https://openalex.org/I4210102855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5158448047","display_name":"Jun Yan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102855","display_name":"First Affiliated Hospital of Heilongjiang University of Chinese Medicine","ror":"https://ror.org/01c0exk17","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210102855"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jun Yan","raw_affiliation_strings":["The Second Department of Oncology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Second Department of Oncology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine","institution_ids":["https://openalex.org/I4210102855"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5158448047"],"corresponding_institution_ids":["https://openalex.org/I4210102855"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.547149,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1958441","last_page":"1958441"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9890000224113464},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9670000076293945},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.9330000281333923},{"id":"https://openalex.org/keywords/colitis","display_name":"colitis","score":0.8009999990463257},{"id":"https://openalex.org/keywords/tumor-reactive-t-cells","display_name":"tumor-reactive T cells","score":0.699999988079071},{"id":"https://openalex.org/keywords/epithelial-barrier-disruption","display_name":"epithelial barrier disruption","score":0.7459999918937683},{"id":"https://openalex.org/keywords/innate-inflammation","display_name":"innate inflammation","score":0.7570000290870667},{"id":"https://openalex.org/keywords/il-5","display_name":"IL-5","score":0.8080000281333923},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.996999979019165},{"id":"https://openalex.org/keywords/jak-inhibition","display_name":"JAK inhibition","score":0.8610000014305115},{"id":"https://openalex.org/keywords/nlrp3-inflammasome","display_name":"NLRP3 inflammasome","score":0.9909999966621399},{"id":"https://openalex.org/keywords/glucocorticoids","display_name":"glucocorticoids","score":0.7710000276565552},{"id":"https://openalex.org/keywords/immune-regulation","display_name":"immune regulation","score":0.3449999988079071},{"id":"https://openalex.org/keywords/shared-tumor-antigens","display_name":"shared tumor antigens","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.7390000224113464},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6608999967575073},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.5253000259399414},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4823000133037567},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40209999680519104},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3880999982357025},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38269999623298645},{"id":"https://openalex.org/C2778426790","wikidata":"https://www.wikidata.org/wiki/Q1649580","display_name":"Organ dysfunction","level":3,"score":0.3619999885559082},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.353300005197525},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.3440000116825104},{"id":"https://openalex.org/C81444415","wikidata":"https://www.wikidata.org/wiki/Q7243535","display_name":"Priming (agriculture)","level":3,"score":0.3422999978065491},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.3240000009536743},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.32359999418258667},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.32010000944137573},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.29440000653266907},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.2865999937057495},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2759999930858612},{"id":"https://openalex.org/C19106626","wikidata":"https://www.wikidata.org/wiki/Q230749","display_name":"Bystander effect","level":2,"score":0.27309998869895935},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.26669999957084656}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009928","descriptor_name":"Organ Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2026.1958441","doi":"https://doi.org/10.3389/fimmu.2026.1958441","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1958441","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1958441/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13696943","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13696943/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13696943/pdf/fimmu-17-1958441.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:42935710","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42935710","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:c469d7f0e0314e9da02b350db0bb1226","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c469d7f0e0314e9da02b350db0bb1226","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1958441","doi":"https://doi.org/10.3389/fimmu.2026.1958441","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1958441","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1958441/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7221544679.pdf","grobid_xml":"https://content.openalex.org/works/W7221544679.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W2547133566","https://openalex.org/W2557336488","https://openalex.org/W2588366403","https://openalex.org/W2781484625","https://openalex.org/W2942467666","https://openalex.org/W2980830192","https://openalex.org/W3037088183","https://openalex.org/W3049649567","https://openalex.org/W3129833353","https://openalex.org/W3170062184","https://openalex.org/W3180594295","https://openalex.org/W3185312425","https://openalex.org/W3210474759","https://openalex.org/W4229365571","https://openalex.org/W4296641854","https://openalex.org/W4296798904","https://openalex.org/W4297497344","https://openalex.org/W4321598981","https://openalex.org/W4361269612","https://openalex.org/W4389346043","https://openalex.org/W4396576955","https://openalex.org/W4396873966","https://openalex.org/W4396966949","https://openalex.org/W4403356813","https://openalex.org/W4403426084","https://openalex.org/W4404339893","https://openalex.org/W4406138946","https://openalex.org/W4413471634","https://openalex.org/W7118358521","https://openalex.org/W7160402500"],"related_works":["https://openalex.org/W3090117161","https://openalex.org/W3000499952","https://openalex.org/W2612002454","https://openalex.org/W7211875947","https://openalex.org/W4367325761","https://openalex.org/W4245096217","https://openalex.org/W2904723051","https://openalex.org/W7167586249","https://openalex.org/W2981320816","https://openalex.org/W4206159727"],"abstract_inverted_index":{"By":[0],"relaxing":[1],"immune":[2,4,57,68],"tolerance,":[3],"checkpoint":[5],"inhibitors":[6],"can":[7,12],"restore":[8],"antitumor":[9,44,132,180,237],"responses":[10],"but":[11,99,162,217],"also":[13,119],"cause":[14],"immune-related":[15],"adverse":[16],"events":[17],"across":[18,51,113],"multiple":[19],"organs.":[20,115],"Efficacy":[21],"and":[22,55,64,70,94,109,140,148,202],"toxicity":[23,74,155,177,213,235],"occur":[24],"together":[25],"in":[26,76,107,156],"some":[27],"patients,":[28],"yet":[29,221],"this":[30],"association":[31],"does":[32,128],"not":[33,129,220],"mean":[34],"that":[35,211,225],"tissue":[36,87,138],"injury":[37,66],"is":[38,105,219],"an":[39,126],"unavoidable":[40],"cost":[41],"of":[42,96,189,196,199,209,234],"effective":[43],"immunity.":[45],"Shared":[46],"antigens,":[47],"lymphocyte":[48],"clones":[49],"expanded":[50],"tissues,":[52],"B-cell":[53],"activation,":[54],"weakened":[56],"regulation":[58],"create":[59],"overlap":[60],"between":[61],"tumor":[62,167,200],"control":[63,168],"normal-tissue":[65],"during":[67],"priming":[69],"effector":[71],"responses.":[72],"Whether":[73],"persists":[75],"a":[77,174],"particular":[78],"organ":[79,127,135,191],"may":[80],"be":[81],"shaped":[82],"by":[83],"local":[84],"antigen":[85],"presentation,":[86],"residency,":[88],"cellular":[89],"interactions,":[90],"epithelial":[91],"barrier":[92],"disruption,":[93],"amplification":[95],"innate":[97],"inflammation,":[98],"direct":[100],"support":[101,120],"for":[102],"these":[103],"processes":[104],"strongest":[106],"colitis":[108],"remains":[110],"less":[111],"complete":[112],"other":[114],"Because":[116],"residency":[117],"programs":[118],"tumor-reactive":[121],"T":[122],"cells,":[123],"localization":[124],"within":[125,185,214],"automatically":[130],"preserve":[131],"activity.":[133],"Restricting":[134],"homing,":[136],"protecting":[137],"barriers,":[139],"targeting":[141],"pathways":[142],"such":[143],"as":[144],"IL-5,":[145],"IL-6,":[146],"JAK,":[147],"NLRP3":[149],"have":[150],"shown":[151],"potential":[152],"to":[153,223],"reduce":[154],"case":[157],"series":[158],"or":[159],"animal":[160],"models,":[161],"their":[163],"effects":[164],"on":[165],"long-term":[166],"remain":[169],"insufficiently":[170],"evaluated.":[171],"Determining":[172],"whether":[173],"treatment":[175],"controls":[176],"while":[178],"preserving":[179],"activity":[181],"requires":[182],"concurrent":[183],"assessment,":[184],"the":[186],"same":[187],"cohort,":[188],"objective":[190],"response,":[192,201],"glucocorticoid":[193],"exposure,":[194],"resumption":[195],"immunotherapy,":[197],"duration":[198],"survival.":[203],"Current":[204],"evidence":[205],"supports":[206],"further":[207],"study":[208],"mechanisms":[210],"sustain":[212],"affected":[215],"organs,":[216],"it":[218],"sufficient":[222],"establish":[224],"most":[226],"candidate":[227],"strategies":[228],"achieve":[229],"durable,":[230],"clinically":[231],"meaningful":[232],"separation":[233],"from":[236],"benefit.":[238]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-10-13T00:00:00"}